Midgard Science

Labs / Assays & in vitro testing

D

Denteric

Malbourne, Australia · denteric.com

On your own

Free. Their own form.

Contact Denteric directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

Denteric develops therapies for diseases related to Porphyromonas gingivalis and chronic inflammation. Its lead program GPV381 is being developed initially for patients with severe or refractory periodontitis, with interest in other diseases including Alzheimer’s disease, diabetes, and cardiovascular disease. The company is based in Melbourne, Australia.

Their website has a general contact form; we send your quote request through it.

What they offer

  • GPV381 development

    Develops GPV381, a novel therapy targeting gingipains from Porphyromonas gingivalis to treat chronic inflammation and periodontitis.

  • Porphyromonas gingivalis-related disease therapy development

    Develops vaccines and therapies for diseases associated with Porphyromonas gingivalis.

What they work on

Modalities
Vaccine
Therapeutic areas
periodontitis, chronic inflammation, Alzheimer’s disease, diabetes, cardiovascular disease
Sites
Melbourne, Australia

Similar labs. JPT Peptide Technologies, 3C Therapeutics, Abeomics, Alphalyse

Found in a contract services directory. Listing built from denteric.com. Work here? Claim this listing.

Denteric · Midgard Science